
Introduction
The medical billing appeals process is the structured method a healthcare provider uses to challenge a payer's denial, underpayment, or adverse claim decision. It follows a defined procedural path with deadlines, evidence requirements, and specific channels.
This guide is written for infectious disease physicians, independent practices, group leaders, and practice administrators. Effective appeals protect cash flow, ensure accurate reimbursement, and keep operations compliant and sustainable.
Denials aren't rare. 41% of providers reported denial rates of 10% or higher, according to Experian Health's survey. That number reflects a survey of billing professionals, not an ID-specific benchmark, but it establishes the scale of the problem.
Appeals get discussed constantly but understood poorly at the operational level. This article covers denial review, documentation, submission, escalation, tracking, and prevention.
Key Takeaways
- An appeal challenges a payer decision; some denials need a corrected claim or resubmission instead
- Strong appeals connect the denial reason to payer policy, claim data, and clinical documentation
- Deadlines and escalation rights vary by payer, plan, contract, and applicable law
- Tracking appeals by payer, reason, value, and outcome exposes preventable revenue-cycle problems
What Is the Appeals Process and Why Is It Used?
A medical billing appeal is a formal, written request asking a payer to reconsider a denied, partially paid, or incorrectly processed claim. Aetna defines it as a request to change or overturn a previous decision, covering grounds like medical necessity, payment policy, and experimental or investigational determinations, according to Aetna's provider guidance.
The goal is correcting an adjudication error and securing payment for a properly supported service, not automatic approval.
Appeal vs. Corrected Claim
These terms get used interchangeably, and that's a mistake. If the payer flags a correctable data or coding error and directs you to submit a replacement, that's a corrected claim, not an appeal. Submitting the same claim again without changes is a resubmission, and it is not a recognized appeal level either.
A true appeal challenges the payer's decision, not the claim's data entry.
Why This Matters More for ID Practices
Infectious disease billing carries unique complexity:
- Extended treatment courses with evolving antimicrobial plans
- OPAT and infusion services requiring documented medical necessity for the specific agent
- Consultation notes and laboratory evidence that must support coding decisions
- Care-transition documentation linking inpatient and outpatient phases
One denied drug claim can represent weeks of acquisition cost already absorbed. In buy-and-bill arrangements, a hard denial is a realized inventory loss on drugs already administered to the patient, not an accounting adjustment.
Appeals also differ from patient insurance appeals, medical-necessity disputes, and prior-authorization disputes. The responsible party and procedural rights shift depending on which category you're in, so confirm which process applies before you start drafting anything.
How the Appeals Process Works
The appeals workflow follows a consistent logical sequence, even though specific rules vary by payer.
Step 1: Review the Denial
Start with the remittance advice or EOB. Identify:
- Adjustment and remark codes
- Claim number and affected service lines
- Relevant payer policy and contract terms
A denial code is a starting point for investigation, not a complete explanation. Reconcile it against the remittance, the policy, and any prior payer correspondence before deciding on next steps.
Step 2: Decide What the Account Needs
Not every denial calls for an appeal. Soft denials (missing information, correctable coding errors) usually just need resubmission or correction.
Hard denials, like timely filing issues or non-covered services, are typically final unless you successfully appeal them, according to Unlimited Systems' RCM glossary. Hard doesn't mean unappealable; it means there's no simple fix available.
Step 3: Verify Deadlines and Submission Requirements
Filing windows differ dramatically by payer type:
| Payer type | Example filing window |
|---|---|
| Medicare Part B (Level 1) | 120 days from initial determination |
| UnitedHealthcare commercial | 12 months total for reconsideration + appeal combined |
| Aetna reconsideration | 180 calendar days |
| Florida Medicaid managed care (Sunshine Health) | 90 days from original payment notice |
Always confirm current requirements directly with the payer rather than relying on a remembered number from last year's contract.
Step 4: Assemble the Package
A focused appeal package includes:
- Appeal letter
- Original claim and remittance notice
- Relevant medical records and coding support
- Authorization evidence and the applicable payer policy
Don't pad it with unrelated records. Excessive documentation slows review and buries the point.
Step 5: Write a Targeted Appeal
Connect the service, diagnosis, documentation, and payer policy into one coherent argument. Cite the specific coverage determination or criterion met, not a general medical-necessity claim.
Step 6: Submit, Track, Escalate
Record the submission date, confirmation number, and expected response window. If the outcome is unfavorable, options may include a higher-level internal appeal, peer-to-peer review, or external review. Verify eligibility under Medicare, Medicaid, ERISA, or state rules first.

Medicare's Original Part B appeals have five defined levels, each with its own deadline, according to CMS's appeals guide:
- MAC redetermination (120 days)
- QIC reconsideration (180 days)
- OMHA ALJ hearing (60 days, minimum amount in controversy applies)
- Medicare Appeals Council review (60 days)
- Federal district court review (60 days, minimum amount in controversy applies)
Commercial payers don't follow this ladder. UnitedHealthcare uses two steps (reconsideration, then appeal) within a combined 12-month window. Don't assume Medicare's structure applies elsewhere.
Where the Appeals Process Applies and What Affects It
Common Denial Categories
Appeals commonly address:
- Medical necessity for the specific antimicrobial agent
- Incorrect coding or administration-coding hierarchy errors
- Missing or expired authorization, including lapses mid-course of therapy
- Site-of-care mismatches
- Drug unit or wastage reporting discrepancies
- Under-documented consultations
Documentation That Supports an ID Appeal
Infectious disease records that strengthen an appeal include:
- Consultation notes
- Treatment rationale tied to culture results
- OPAT orders
- Weekly monitoring reviews
- Care-transition documentation
A weekly OPAT review covering clinical response, lab trends, line status, and treatment duration doubles as appeal support when a denial challenges necessity or duration.
Prioritizing Appeal Work
Rank denials by dollar value, not count. A count-based report can invert the priority completely: ten small denials matter less than one denied infusion claim representing a month of acquisition cost.
Track hard-denial dollars separately from soft-denial dollars, since the former represent realized losses rather than temporary delays.

Useful factors for prioritization:
- Financial value of the claim
- Likelihood of recovery based on payer pattern
- Filing deadline proximity
- Staff effort required relative to the claim's value
There's no universal return-on-effort threshold here. Each practice has to weigh this against its own payer mix and staffing capacity.
Measuring Performance
Track these from your own data rather than generalized rates:
- Appeal volume and overturn rate
- Recovery amount by payer and denial type
- Days to resolution
- Net collection rate against contracted entitlement
- A/R over 90 days, where authorization and drug-claim problems accumulate first
Underpayment on drug claims is invisible without contracted rates loaded into your system. Without that baseline, a "paid" claim can quietly be an underpaid one.
For ID practices evaluating these issues with their own numbers, payer mix, and OPAT or infusion workflows, GrowInfectiousDisease offers free tools built for this kind of operational assumption-checking.
Common Issues and When an Appeal May Not Be Appropriate
Not every denial is appealable. Some claims fall outside the filing window, get excluded by the patient's plan terms, or lack documentation that simply doesn't exist. In those cases, a corrected claim, resubmission, or documented write-off is the right move, not a doomed appeal.
Frequent Process Failures
Watch for these recurring mistakes:
- Missed filing deadlines
- Generic appeal letters that don't cite specific policy language
- Incomplete evidence packages
- Wrong payer address, portal, or fax number
- Missing claim identifiers
- No documentation of prior payer phone calls
- No follow-up after submission
When to Escalate
Escalation (peer-to-peer review, provider-relations outreach, external review, or formal complaint) may be appropriate when internal appeals fail. But verify eligibility, jurisdiction, and plan type first. Not all denials qualify for external review; for example, federal rules exclude denials based solely on eligibility from that process.

One warning worth repeating: never use clinical documentation, coding changes, or authorization records to manufacture support after the fact. Keep records accurate, protect patient privacy, and bring in qualified billing, compliance, or legal professionals when a case is genuinely ambiguous. Billing teams credentialed in CPC, CPB, RHIT, or CCS coding standards exist precisely for this kind of judgment call.
Conclusion
A successful appeals process combines accurate denial classification, a defensible evidence package, payer-specific submission, deadline discipline, and documented follow-up through escalation if needed.
Understanding this process helps infectious disease practices protect legitimate reimbursement while surfacing the preventable workflow, documentation, authorization, and coding problems behind recurring denials.
The goal is selective appeals: apply the process correctly, back each case with evidence, and measure results against your own payer mix and financial data rather than someone else's benchmark.
Frequently Asked Questions
What is an appeal in medical billing?
An appeal is a formal, written request asking a payer to reconsider a denied, underpaid, or incorrectly processed claim. It differs from a corrected claim or resubmission, which addresses data or coding errors rather than disputing the payer's decision itself.
What are the five levels of appeal in medical billing?
There's no single five-level sequence that applies to every payer. Original Medicare Part B has five defined levels, but commercial payers like UnitedHealthcare use just two steps. Always verify the applicable rules for the specific payer and plan.
What are valid reasons to file an appeal in medical billing?
Valid reasons include apparent adjudication errors, supported medical necessity, incorrect coding interpretation, documented authorization compliance, and underpayment against contracted rates. The denial notice and payer rules determine which remedy actually applies.
What are the top reasons claims are denied in medical billing?
Common causes include eligibility errors, authorization issues, coding or modifier problems, missing documentation, medical-necessity disputes, and untimely filing. MGMA's 2024 survey ranked authorization and documentation gaps among top causes; still, analyze your own denial data.


